336 related articles for article (PubMed ID: 31465112)
1. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
[TBL] [Abstract][Full Text] [Related]
2. Identification of Prognostic Biomarkers in the Urinary Peptidome of the Small Renal Mass.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
Am J Pathol; 2019 Dec; 189(12):2366-2376. PubMed ID: 31761032
[TBL] [Abstract][Full Text] [Related]
3. Prognostic urinary miRNAs for the assessment of small renal masses.
Di Meo A; Brown MD; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
Clin Biochem; 2020 Jan; 75():15-22. PubMed ID: 31672647
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive urine markers for the differentiation between RCCs and oncocytoma.
von Brandenstein M; Herden J; Köditz B; Huerta M; Nestler T; Heidenreich A; Fries JWU
J Clin Lab Anal; 2021 May; 35(5):e23762. PubMed ID: 33960011
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
8. Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma.
Papale M; Vocino G; Lucarelli G; Rutigliano M; Gigante M; Rocchetti MT; Pesce F; Sanguedolce F; Bufo P; Battaglia M; Stallone G; Grandaliano G; Carrieri G; Gesualdo L; Ranieri E
Oncotarget; 2017 Jun; 8(25):40412-40424. PubMed ID: 28418894
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide promoter methylome of small renal masses.
Ibragimova I; Slifker MJ; Maradeo ME; Banumathy G; Dulaimi E; Uzzo RG; Cairns P
PLoS One; 2013; 8(10):e77309. PubMed ID: 24204800
[TBL] [Abstract][Full Text] [Related]
11. Accurate quantification of urinary metabolites for predictive models manifest clinicopathology of renal cell carcinoma.
Sato T; Kawasaki Y; Maekawa M; Takasaki S; Shimada S; Morozumi K; Sato M; Kawamorita N; Yamashita S; Mitsuzuka K; Mano N; Ito A
Cancer Sci; 2020 Jul; 111(7):2570-2578. PubMed ID: 32350988
[TBL] [Abstract][Full Text] [Related]
12. Tumor size, stage and grade alterations of urinary peptidome in RCC.
Chinello C; Cazzaniga M; De Sio G; Smith AJ; Grasso A; Rocco B; Signorini S; Grasso M; Bosari S; Zoppis I; Mauri G; Magni F
J Transl Med; 2015 Oct; 13():332. PubMed ID: 26482227
[TBL] [Abstract][Full Text] [Related]
13. Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort.
Finelli A; Cheung DC; Al-Matar A; Evans AJ; Morash CG; Pautler SE; Siemens DR; Tanguay S; Rendon RA; Gleave ME; Drachenberg DE; Chin JL; Fleshner NE; Haider MA; Kachura JR; Sykes J; Jewett MAS
Eur Urol; 2020 Sep; 78(3):460-467. PubMed ID: 32680677
[TBL] [Abstract][Full Text] [Related]
14. Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro.
Zieren RC; Dong L; Clark DJ; Kuczler MD; Horie K; Moreno LF; Lih TM; Schnaubelt M; Vermeulen L; Zhang H; de Reijke TM; Pienta KJ; Amend SR
Med Oncol; 2021 Jul; 38(9):105. PubMed ID: 34331598
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted imaging using 3.0 T MRI as a possible biomarker of renal tumors.
Mirka H; Korcakova E; Kastner J; Hora M; Hes O; Hosek P; Ferda J
Anticancer Res; 2015 Apr; 35(4):2351-7. PubMed ID: 25862900
[TBL] [Abstract][Full Text] [Related]
16. Imaging findings of common benign renal tumors in the era of small renal masses: differential diagnosis from small renal cell carcinoma: current status and future perspectives.
Woo S; Cho JY
Korean J Radiol; 2015; 16(1):99-113. PubMed ID: 25598678
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
18. Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma.
Chinello C; Stella M; Piga I; Smith AJ; Bovo G; Varallo M; Ivanova M; Denti V; Grasso M; Grasso A; Del Puppo M; Zaravinos A; Magni F
J Proteomics; 2019 Jan; 191():29-37. PubMed ID: 29689304
[TBL] [Abstract][Full Text] [Related]
19. Urine Molecular Biomarkers for Detection and Follow-Up of Small Renal Masses.
Žalimas A; Kubiliūtė R; Žukauskaitė K; Sabaliauskaitė R; Trakymas M; Letautienė S; Kaubrienė EM; Ušinskienė J; Ulys A; Jarmalaitė S
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555747
[TBL] [Abstract][Full Text] [Related]
20. Incremental Expression of 14-3-3 Protein Beta/Alpha in Urine Correlates with Advanced Stage and Poor Survival in Patients with Clear Cell Renal Cell Carcinoma.
Kaneko S; Matsumoto K; Minamida S; Hirayama T; Fujita T; Kodera Y; Iwamura M
Asian Pac J Cancer Prev; 2016; 17(3):1399-404. PubMed ID: 27039779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]